{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:37:41Z","timestamp":1790419061987,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Fonds voor Wetenschappelijk Onderzoek Vlaanderen","award":["G031915N"],"award-info":[{"award-number":["G031915N"]}]},{"name":"Systems Biology for the Functional Validation of Genetic Determinants of Skeletal Diseases project SYBIL"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Mutations in the LRP4 gene, coding for a Wnt signaling coreceptor, have been found to cause several allelic conditions. Among these, two are characterized by a strong skeletal involvement, namely sclerosteosis and Cenani-Lenz syndrome. In this work, we evaluated the role of LRP4 in the pathophysiology of these diseases. First, we report a novel LRP4 mutation, leading to the substitution of arginine at position 1170 in glutamine, identified in a patient with sclerosteosis. This mutation is located in the central cavity of the third \u03b2-propeller domain, which is in line with two other sclerosteosis mutations we previously described. Reporter assays demonstrate that this mutation leads to impaired sclerostin inhibition of Wnt signaling. Moreover, we compared the effect of this novel variant to mutations causing Cenani-Lenz syndrome and show that impaired membrane trafficking of the LRP4 protein is the likely mechanism underlying Cenani-Lenz syndrome. This is in contrast to sclerosteosis mutations, previously shown to impair the binding between LRP4 and sclerostin. In addition, to better understand the biology of LRP4, we investigated the circulating sclerostin levels in the serum of a patient suffering from sclerosteosis owing to a LRP4 mutation. We demonstrate that impaired sclerostin binding to the mutated LRP4 protein leads to dramatic increase in circulating sclerostin in this patient. With this study, we provide the first evidence suggesting that LRP4 is responsible for the retention of sclerostin in the bone environment in humans. These findings raise potential concerns about the utility of determining circulating sclerostin levels as a marker for other bone-related parameters. Although more studies are needed to fully understand the mechanism whereby LRP4 facilitates sclerostin action, it is clear that this protein represents a potent target for future osteoporosis therapies and an interesting alternative for the antisclerostin treatment currently under study. \u00a9 2016 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2782","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T20:30:00Z","timestamp":1452544200000},"page":"874-881","source":"Crossref","is-referenced-by-count":77,"title":["A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone"],"prefix":"10.1093","volume":"31","author":[{"given":"Igor","family":"Fijalkowski","sequence":"first","affiliation":[{"name":"Department of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Geets","sequence":"additional","affiliation":[{"name":"Department of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Steenackers","sequence":"additional","affiliation":[{"name":"Department of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Van Hoof","sequence":"additional","affiliation":[{"name":"Department of Clinical ChemistryAntwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciano J","family":"Ramos","sequence":"additional","affiliation":[{"name":"Unidad de Gen\u00e9ticaServicio de PediatriaHospital Clinico Universitario \u201cLozano Blesa\u201d, GCV-CIBERER, Facultad de Medicina, Universidad de ZaragozaZaragozaSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Mortier","sequence":"additional","affiliation":[{"name":"Department of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Fortuna","sequence":"additional","affiliation":[{"name":"Centro de Gen\u00e9tica M\u00e9dica, Centro Hospitalar do Porto, and Unit for Multidisciplinary Research in BiomedicineUMIB, ICBAS-UP,PortoPortugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Hul","sequence":"additional","affiliation":[{"name":"Department of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Boudin","sequence":"additional","affiliation":[{"name":"Department of Medical GeneticsUniversity of Antwerp and Antwerp University HospitalAntwerpBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"issue":"4","key":"2024021014175953400_jbmr2782-bib-0001","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jbmr.1794","article-title":"Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers","volume":"28","author":"van Lierop","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024021014175953400_jbmr2782-bib-0002","first-page":"209","article-title":"Osteopetrosis with syndactyly; a morphological variant of Albers-Schonberg's disease","volume":"40-B","author":"Truswell","year":"1958","journal-title":"J Bone Joint Surg Br"},{"issue":"1","key":"2024021014175953400_jbmr2782-bib-0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.1977.tb01269.x","article-title":"Sclerosteosis\u2014an autosomal recessive disorder","volume":"11","author":"Beighton","year":"1977","journal-title":"Clin Genet"},{"issue":"5","key":"2024021014175953400_jbmr2782-bib-0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2024021014175953400_jbmr2782-bib-0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2024021014175953400_jbmr2782-bib-0006","doi-asserted-by":"crossref","first-page":"E1526","DOI":"10.1002\/humu.21274","article-title":"First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function","volume":"31","author":"Piters","year":"2010","journal-title":"Hum Mutat"},{"issue":"2","key":"2024021014175953400_jbmr2782-bib-0007","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1086\/301721","article-title":"Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21","volume":"62","author":"Van Hul","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2024021014175953400_jbmr2782-bib-0008","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/302416","article-title":"Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21","volume":"64","author":"Balemans","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2024021014175953400_jbmr2782-bib-0009","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am J Med Genet"},{"issue":"2","key":"2024021014175953400_jbmr2782-bib-0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52\u2009kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet"},{"issue":"7","key":"2024021014175953400_jbmr2782-bib-0011","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res"},{"issue":"12","key":"2024021014175953400_jbmr2782-bib-0012","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1359\/jbmr.070804","article-title":"Control of the SOST bone enhancer by PTH using MEF2 transcription factors","volume":"22","author":"Leupin","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"29","key":"2024021014175953400_jbmr2782-bib-0013","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"J Biol Chem"},{"issue":"6)","key":"2024021014175953400_jbmr2782-bib-0014","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","article-title":"The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations","volume":"82","author":"Balemans","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"2024021014175953400_jbmr2782-bib-0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2024021014175953400_jbmr2782-bib-0016","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"2024021014175953400_jbmr2782-bib-0017","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jbmr.2092","article-title":"Single- and multiple-dose randomized studies of blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women","volume":"29","author":"McColm","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024021014175953400_jbmr2782-bib-0018","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","article-title":"Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo","volume":"4","author":"Choi","year":"2009","journal-title":"PloS One"},{"issue":"22","key":"2024021014175953400_jbmr2782-bib-0019","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J Biol Chem"},{"issue":"24","key":"2024021014175953400_jbmr2782-bib-0020","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1242\/dev.02696","article-title":"LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction","volume":"133","author":"Weatherbee","year":"2006","journal-title":"Development"},{"issue":"22","key":"2024021014175953400_jbmr2782-bib-0021","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/hmg\/ddi381","article-title":"Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice","volume":"14","author":"Johnson","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"48","key":"2024021014175953400_jbmr2782-bib-0022","doi-asserted-by":"crossref","first-page":"E5187","DOI":"10.1073\/pnas.1413828111","article-title":"Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2024021014175953400_jbmr2782-bib-0023","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1073\/pnas.1419714112","article-title":"Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption","volume":"112","author":"Xiong","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2024021014175953400_jbmr2782-bib-0024","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2010.03.004","article-title":"LRP4 mutations alter Wnt\/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome","volume":"86","author":"Li","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2024021014175953400_jbmr2782-bib-0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00438491","article-title":"[Total syndactylia and total radioulnar synostosis in 2 brothers. A contribution on the genetics of syndactylia]","volume":"101","author":"Cenani","year":"1967","journal-title":"Zeitschrift fur Kinderheilkunde"},{"issue":"9","key":"2024021014175953400_jbmr2782-bib-0026","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/ajmg.a.36647","article-title":"Truncating mutations in LRP4 lead to a prenatal lethal form of Cenani-Lenz syndrome","volume":"164A","author":"Lindy","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"42","key":"2024021014175953400_jbmr2782-bib-0027","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1523\/JNEUROSCI.1733-14.2014","article-title":"LRP4 is critical for neuromuscular junction maintenance","volume":"34","author":"Barik","year":"2014","journal-title":"J Neurosci"},{"issue":"2","key":"2024021014175953400_jbmr2782-bib-0028","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"issue":"4","key":"2024021014175953400_jbmr2782-bib-0029","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"issue":"3","key":"2024021014175953400_jbmr2782-bib-0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"issue":"7","key":"2024021014175953400_jbmr2782-bib-0031","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","article-title":"LRP4 third beta-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner","volume":"23","author":"Ohkawara","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2024021014175953400_jbmr2782-bib-0032","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bone.2011.05.006","article-title":"Identification of the first deletion in the LRP5 gene in a patient with autosomal dominant osteopetrosis type I","volume":"49","author":"Pangrazio","year":"2011","journal-title":"Bone"},{"issue":"9","key":"2024021014175953400_jbmr2782-bib-0033","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/clinchem\/34.9.1853","article-title":"Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum","volume":"34","author":"Van Hoof","year":"1988","journal-title":"Clin Chem"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2782","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/4\/874\/56650674\/jbmr2782.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/4\/874\/56650674\/jbmr2782.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:55:44Z","timestamp":1710341744000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/31\/4\/874-881\/7605355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,1,11]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2782","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,4,1]]},"published":{"date-parts":[[2016,1,11]]}}}